Joint clinical assessments should also be carried out on certain medical devices as defined in Regulation (EU) 2017/745 of the European Parliament and of the Council [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1).] which are in the highest risk classes and for which the relevant expert panels referred to in Article 106(1) of that Regulation have provided their opinions or views, as well as on in vitro diagnostic medical devices classified as class D pursuant to Regulation (EU) 2017/746 of the European Parliament and of the Council [Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176).].
Recital 17, Regulation (EU) 2021/2282
In forcesince 15 Dec 2021
Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January…Law
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 Novembe…Law
- celex=31990L0385
- celex=31993L0042
- celex=31998L0079
- num:eu=1990/385
- num:eu=1993/42